Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.

Saved in:
Bibliographic Details
Title: Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
Authors: Sundy JS (AUTHOR), Baraf HS (AUTHOR), Yood RA (AUTHOR), Edwards NL (AUTHOR), Gutierrez-Urena SR (AUTHOR), Treadwell EL (AUTHOR), Vázquez-Mellado J (AUTHOR), White WB (AUTHOR), Lipsky PE (AUTHOR), Horowitz Z (AUTHOR), Huang W (AUTHOR), Maroli AN (AUTHOR), Waltrip RW 2nd (AUTHOR), Hamburger SA (AUTHOR), Becker MA (AUTHOR), Sundy, John S1 (AUTHOR), Baraf, Herbert S B (AUTHOR), Yood, Robert A (AUTHOR), Edwards, N Lawrence (AUTHOR), Gutierrez-Urena, Sergio R (AUTHOR)
Source: JAMA: Journal of the American Medical Association. 8/17/2011, Vol. 306 Issue 7, p711-720. 10p.
Database: Academic Search Ultimate
Description
ISSN:00987484
DOI:10.1001/jama.2011.1169